(HealthDay)—Acute kidney injury (AKI) in hospitalized patients with COVID-19 is associated with a significantly higher…
View More Acute kidney injury ups risk for death in COVID-19 patients
Heavy Sugar-Sweetened Drink Intake Decreasing Overall in U.S.
THURSDAY, Sept. 24, 2020 — Overall, heavy sugar-sweetened beverage (SSB) intake is declining among adults…
View More Heavy Sugar-Sweetened Drink Intake Decreasing Overall in U.S.
Researchers find a protein involved in Huntington’s disease motor deficits
Huntington’s disease is caused by a mutation in the Huntingtin gen. Patients show involuntary movements,…
View More Researchers find a protein involved in Huntington’s disease motor deficits
U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States
WEDNESDAY, Sept. 23, 2020 — The U.S. COVID-19 death toll reached the tragic milestone of…
View More U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States
The geographic bias in medical AI tools
Just a few decades ago, scientists didn’t think much about diversity when studying new medications.…
View More The geographic bias in medical AI tools
Research indicates 86 percent of high risk individuals in the UK would take up COVID-19 vaccine
A study has suggested that 86 percent of high risk individuals in the UK would…
View More Research indicates 86 percent of high risk individuals in the UK would take up COVID-19 vaccine
Once-a-week insulin for type 2 diabetes shows promise in early trial
(HealthDay)—Type 2 diabetes can be tough to control without medication. But for some people, the…
View More Once-a-week insulin for type 2 diabetes shows promise in early trial
Cannabinoids decrease the metabolism of glucose in the brain
The nervous system comprises neurons and glial cells (glia means ‘glue’). Astrocytes are the most…
View More Cannabinoids decrease the metabolism of glucose in the brain
Study links higher level of exercise to 25% to 32% lower risk of all-cause mortality in people with type 2 diabetes
New research presented at this year’s Annual Meeting of the European Association for the Study…
View More Study links higher level of exercise to 25% to 32% lower risk of all-cause mortality in people with type 2 diabetes
Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients with HER3 Expressing Advanced Colorectal Cancer
Tokyo, Basking Ridge, N.J. and Munich – (September 14, 2020) – Daiichi Sankyo Company, Limited (hereafter,…
View More Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients with HER3 Expressing Advanced Colorectal Cancer